{"id":184829,"date":"2017-03-27T04:23:16","date_gmt":"2017-03-27T08:23:16","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/novartis-cosentyx-shows-psoriasis-modification-potential-nvs-derm-investopedia\/"},"modified":"2017-03-27T04:23:16","modified_gmt":"2017-03-27T08:23:16","slug":"novartis-cosentyx-shows-psoriasis-modification-potential-nvs-derm-investopedia","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/novartis-cosentyx-shows-psoriasis-modification-potential-nvs-derm-investopedia\/","title":{"rendered":"Novartis’ Cosentyx Shows Psoriasis Modification Potential (NVS, DERM) – Investopedia"},"content":{"rendered":"
\"\"
Investopedia<\/font><\/a><\/font><\/td>
\"\"<\/div>
Novartis' Cosentyx Shows Psoriasis<\/b> Modification Potential (NVS, DERM)<\/b><\/a>
Investopedia<\/font><\/b><\/font>
has reported new data which suggests that its key psoriasis<\/b> therapy, Cosentyx (secukinumab), has demonstrated the potential to modify the course of moderate-to-severe psoriasis<\/b>, offering new hope of a more efficient treatment. Disease modification is ...<\/b><\/font>
Threats And Opportunities In Psoriasis<\/b>: What's Next For Novartis?<\/a>Seeking Alpha<\/nobr><\/font><\/font>
Novartis boasts a big new advantage for Cosentyx as data indicate the blockbuster can modify psoriasis<\/b><\/a>Endpoints News<\/nobr><\/font><\/font>
Novartis' Cosentyx is first and only IL-17A inhibitor to potentially ...<\/a>Yahoo Finance<\/nobr><\/font><\/font>
PharmaTimes<\/nobr><\/a> -Healio<\/nobr><\/a> -pharmaphorum<\/nobr><\/a><\/font>
all 11 news articles »<\/b><\/nobr><\/a><\/font><\/div>

<\/p><\/font><\/td><\/tr><\/table>

<\/p>

Excerpt from:
Novartis' Cosentyx Shows Psoriasis Modification Potential (NVS, DERM) - Investopedia<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Investopedia Novartis' Cosentyx Shows Psoriasis Modification Potential (NVS, DERM) Investopedia has reported new data which suggests that its key psoriasis therapy, Cosentyx (secukinumab), has demonstrated the potential to modify the course of moderate-to-severe psoriasis , offering new hope of a more efficient treatment. Disease modification is .. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-184829","post","type-post","status-publish","format-standard","hentry","category-psoriasis"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/184829"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=184829"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/184829\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=184829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=184829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=184829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}